Annual Operating Margin
-58.10 K%
+87.99 K%+60.23%
December 31, 2023
Summary
- As of February 12, 2025, IBRX annual operating profit margin is -58.10 thousand%, with the most recent change of +87.99 thousand% (+60.23%) on December 31, 2023.
- During the last 3 years, IBRX annual operating margin has fallen by -23.35 thousand% (-67.20%).
- IBRX annual operating margin is now -718.75% below its all-time high of -7095.87%, reached on December 31, 2019.
Performance
IBRX Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Operating Margin
-1314.33%
+8173.06%+86.15%
September 30, 2024
Summary
- As of February 12, 2025, IBRX quarterly operating profit margin is -1314.33%, with the most recent change of +8173.06% (+86.15%) on September 30, 2024.
- Over the past year, IBRX quarterly operating margin has increased by +8173.06% (+86.15%).
- IBRX quarterly operating margin is now at all-time high.
Performance
IBRX Quarterly Operating Margin Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Operating Margin Formula
Operating Profit Margin = Operating Profit
Revenue ✕ 100%
Revenue ✕ 100%
IBRX Operating Margin Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +60.2% | +86.2% |
| 3 y3 years | -67.2% | +99.4% |
| 5 y5 years | -718.8% | +99.4% |
IBRX Operating Margin Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -64.3% | +60.2% | at high | +99.8% |
| 5 y | 5-year | -718.8% | +60.2% | at high | +99.8% |
| alltime | all time | -718.8% | +60.2% | at high | +99.8% |
ImmunityBio Operating Margin History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | -1314.33%(-86.1%) |
| Jun 2024 | - | -9487.39%(-96.0%) |
| Mar 2024 | - | -237.99 K%(+291.5%) |
| Dec 2023 | -58.10 K%(-60.2%) | -60.79 K%(-37.8%) |
| Sep 2023 | - | -97.73 K%(-52.9%) |
| Jun 2023 | - | -207.67 K%(+570.0%) |
| Mar 2023 | - | -30.99 K%(-73.1%) |
| Dec 2022 | -146.09 K% | -115.37 K%(+49.9%) |
| Sep 2022 | - | -76.95 K%(-66.2%) |
| Jun 2022 | - | -227.49 K%(-66.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2022 | - | -685.51 K%(+3272.5%) |
| Dec 2021 | -35.36 K%(+1.8%) | -20.33 K%(-83.0%) |
| Sep 2021 | - | -119.45 K%(+371.4%) |
| Jun 2021 | - | -25.34 K%(-59.2%) |
| Mar 2021 | - | -62.06 K%(+69.7%) |
| Dec 2020 | -34.75 K%(+389.7%) | - |
| Sep 2020 | - | -36.57 K%(+213.1%) |
| Jun 2020 | - | -11.68 K%(-47.5%) |
| Mar 2020 | - | -22.24 K% |
| Dec 2019 | -7095.87% | - |
FAQ
- What is ImmunityBio annual operating profit margin?
- What is the all time high annual operating margin for ImmunityBio?
- What is ImmunityBio annual operating margin year-on-year change?
- What is ImmunityBio quarterly operating profit margin?
- What is the all time high quarterly operating margin for ImmunityBio?
- What is ImmunityBio quarterly operating margin year-on-year change?
What is ImmunityBio annual operating profit margin?
The current annual operating margin of IBRX is -58.10 K%
What is the all time high annual operating margin for ImmunityBio?
ImmunityBio all-time high annual operating profit margin is -7095.87%
What is ImmunityBio annual operating margin year-on-year change?
Over the past year, IBRX annual operating profit margin has changed by +87.99 K% (+60.23%)
What is ImmunityBio quarterly operating profit margin?
The current quarterly operating margin of IBRX is -1314.33%
What is the all time high quarterly operating margin for ImmunityBio?
ImmunityBio all-time high quarterly operating profit margin is -1314.33%
What is ImmunityBio quarterly operating margin year-on-year change?
Over the past year, IBRX quarterly operating profit margin has changed by +8173.06% (+86.15%)